Avalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases. Our lead candidate, AP01, is a Phase 2b-ready inhaled formulation of pirfenidone in development for the treatment of pulmonary fibrosis
View Top Employees from Avalyn Pharma Inc.| Website | http://www.avalynpharma.com |
| Revenue | $2.4 million |
| Employees | 31 (19 on RocketReach) |
| Founded | 2011 |
| Phone | (619) 992-6488 |
| Industry | Biotechnology Research, Pharmaceuticals, Pharmaceutical, Drug Discovery, Healthcare, Health Care, Other Healthcare Services, Biotechnology, Drug Manufacturing & Research |
| Competitors | Encycle Therapeutics Inc, Galectin Therapeutics, Indalo Therapeutics, Metro Medical Supply, Inc., iBio, Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Avalyn Pharma Inc. employee's phone or email?
Avalyn Pharma Inc. Questions
The Avalyn Pharma Inc. annual revenue was $2.4 million in 2024.
Lyn Baranowski is the CEO of Avalyn Pharma Inc..
19 people are employed at Avalyn Pharma Inc..
Avalyn Pharma Inc. is based in Cambridge, Massachusetts.
The NAICS codes for Avalyn Pharma Inc. are [32, 325, 3254, 32541].
The SIC codes for Avalyn Pharma Inc. are [283, 28].
Top Avalyn Pharma Inc. Employees
-
5+5+
-
55+
-
25+
-
54
-
22
-
View
Lisa Freeman
Executive Director, Clinical Development Operations at Avalyn Pharma Inc.
Port Ludlow, WA, US32 -
42
-
5+5
-
31
Related Companies
